|
Individuals with ME/CFS, n (%)
|
75 (74.3%)
|
26 (25.8%)
|
101 (100%)
|
|
Mean age, years (range)
|
48.9 (18–76)
|
52.2 (28–84)
|
49.7 (18–84)
|
|
Duration of illness, years (range)
|
12.6 (2–54)
|
15.8 (1–44)
|
13.4 (1–54)
|
|
Female, n (%)
|
52 (69.4%)
|
16 (61.5%)
|
68 (67%)
|
|
Male, n (%)
|
23 (30.6%)
|
10 (38.5%)
|
33 (33%)
|
|
Aripiprazole dose, mg (range)
|
1.2 (0.25–2.0)
|
0.7 (0–2.0)
|
1.1 (0–2.0)
|
|
Duration of treatment, average months (range)
|
8.0 (0–17)
|
7.1 (0–13)
|
7.8 (0–17)
|
|
Concurrent antidepressant use
|
46/75 (61.3%)*
|
11/26 (42.3%)*
|
57/101 (56.4%)
|
